Business Wire

ADVA

1.6.2022 09:02:07 CEST | Business Wire | Press release

Share
ADVA launches GPS-backup-as-a-service to help service providers combat GNSS cyberattacks

ADVA (FSE: ADV) today announced that it’s enabling service provider customers to offer GPS/GNSS-backup-as-a-service (GBaaS). A wide range of industries are increasingly reliant on satellite-delivered timing, but with threats including jamming and spoofing cyberattacks on the rise, operators need to find ways to safeguard services that rely on positioning, navigation, and timing (PNT) information. In-network timing based on NTP and PTP is also increasingly vulnerable to cyber threats. As a response, ADVA is now empowering service providers to offer GBaaS and enable end users to address new guidelines and standards for redundant PNT architectures. GBaaS meets the latest recommendations for PNT homeland security like US Executive Order 13905. Leveraging ADVA’s aPNT+™ technology , it eliminates the risks and costs associated with GNSS dependence.

“Threats to hamper PNT capabilities are growing, and much of the world’s critical infrastructure is still without adequate protection from GNSS vulnerabilities. All of that can change when service providers are able to offer GBaaS. It’s based on our aPNT+ platform, which leverages a suite of technologies, including multi-band GNSS receivers and AI- and ML-based management software. As well as making networks more resilient against cyberattacks, our aPNT+ platform also delivers highly accurate backup when GNSS fails,” said Gil Biran, GM of Oscilloquartz, ADVA. “Now service providers can offer ADVA’s aPNT+ protection as a subscription-based service as part of their SLAs. This will enable many more timing networks to achieve very high levels of resilience and assurance. Across a wide range of industries, this will be the easiest and most flexible way to guarantee robust PNT services.”

ADVA’s GBaaS solution employs a combination of multi-layer detection, multi-source backup and fault-tolerant mitigation to render timing networks more secure. Embedded in all timing devices, ADVA’s Syncjack technology provides comprehensive and precise synchronization performance monitoring and analytics, enabling the Ensemble Sync Director network management suite to intelligently operate and prioritize multi-source timing feeds across the network. Onboard multi-band GNSS receivers boost timing accuracy and also protect against attacks like jamming and spoofing. But for those times when GNSS is either unavailable or compromised, a dispersed network of autonomous cesium atomic clocks and network backup timing feeds is always sitting on standby, ready to deliver highly accurate network timing over long periods of GNSS unavailability.

“GBaaS is a completely new way for service providers to sell critical PNT infrastructure as a service without the burden of investment and maintenance. For the first time, they can offer their customers SLAs at a range of levels that ensure the resilient and assured timing needed across time-sensitive networks and applications,” commented Nino De Falcis, senior director of business development at Oscilloquartz, ADVA. “The flexibility and protection that GBaaS affords is bad news for any malicious actors looking to attack PNT services. Service providers can now offer their customers a guarantee: When GNSS is compromised or goes offline, ADVA’s robust network of defense-in-depth PTP timing devices will be there to provide the accuracy and backup they urgently need.”

Further information on ADVA’s GBaaS solution is available in these slides: https://adva.li/gbaas-slides .

About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye